Caricamento...
Will Remdesivir Reshape Cardiovascular Practice in COVID 19 Era?
Infection with the novel coronavirus, SARS-CoV2, produces the clinical syndrome COVID-19. COVID-19 is a systemic illness inducing hyperinflammation and cytokine storm affecting multiple organs including the myocardium which is reflected in elevated cardiac biomarkers such as troponin, lactate dehydr...
Salvato in:
| Pubblicato in: | Int J Angiol |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Thieme Medical Publishers, Inc.
2021
|
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8159607/ https://ncbi.nlm.nih.gov/pubmed/34054274 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0040-1721403 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|